COMMUNIQUÉS West-GlobeNewswire

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
10/09/2026
New production framework designed to support continuous manufacturing, greater operating efficiency and long-term program visibility LITTLETON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc [...]
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
10/09/2026
Omada expects to continue to grow revenue at least 20% annually, and updates long-term non-GAAP gross margin target to 80% and adjusted EBITDA margin target to 30% SAN FRANCISCO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Omada [...]
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today [...]
Vanquish Brands Partners with Select BC Craft Growers to Bring Premium Cannabis to Markets Across Canada Via the Pistol and Paris Brand
10/09/2026
AGASSIZ, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Vanquish Holdings Inc. (“Vanquish”), operating under the Vanquish Brands name, is a Canadian cannabis house-built Legacy to Legal™, combining the standards, [...]
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
10/09/2026
SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced that [...]
Interra Health Adds Support for New GLP-1 Bridge Program, Helping Seniors on Medicare Access Weight-Loss Medications
10/09/2026
Within just two months, the program has reached 30,000+ prescribers and delivered 170,000+ point-of-prescribe alerts, helping Medicare patients access GLP-1 medication for obesity for just $50/month BOSTON, Sept. 10, [...]
UPDATE -- Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
10/09/2026
PARAMUS, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, today [...]
Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative
10/09/2026
TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Nuclear Isotope Council (CNIC) today announced Canada’s first official contribution to the International Atomic Energy Agency’s (IAEA) Rays of Hope initiative, a [...]
Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment
10/09/2026
Access the segment here ISELIN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab- [...]
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
10/09/2026
Collaboration with NCI's Cancer Therapy Evaluation Program (CTEP) will evaluate IMNN-001 in new indications and combination regimens IMUNON retains ownership of its background intellectual property with an opportunity [...]
Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer
10/09/2026
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Lead program SC6177 is advancing toward the clinic with a first-in-class approach to restoring lysosomal function, a [...]
Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34
10/09/2026
Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson’s disease (PD), with pharmacokinetics confirming robust CNS exposure Early biomarker signals are consistent [...]
Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
10/09/2026
Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company's Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, Sept. 10, [...]
EPIK Biosciences Advances Combination Medicines Across Ketamine-Based and DXM-Based Programs, Supported by 34 Provisional Drug Patent Applications
10/09/2026
Over 20 filings are ketamine-based and over 5 are dextromethorphan (DXM)-based; applications total more than 2,700 pages of scientific and technical data; Company expects to disclose the full combination portfolio later [...]
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
10/09/2026
Bâle (Suisse) et Chassieu (France) , 10 sept. 2026 (GLOBE NEWSWIRE) -- Cet accord exclusif couvrira le marché des céréales dans l’Union européenne, au Royaume-Uni, en Ukraine et en Suisse, avec les premiers lancements [...]
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
10/09/2026
Basel, Switzerland and Chassieu, France, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market [...]
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
10/09/2026
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets Axogen’s commercial infrastructure, surgeon relationships [...]
Kestra Names Daniel Finney Vice President of Research & Development
10/09/2026
KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named [...]
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
10/09/2026
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of [...]

Pages